Active Ingredient(s): Aprotinin
FDA Approved: * December 29, 1993
Pharm Company: * BAYER PHARMS
Category: Blood Clotting (Hemostasis)

The drug aprotinin (Trasylol, previously Bayer and now Nordic Group pharmaceuticals), is a small protein bovine pancreatic trypsin inhibitor (BPTI), or basic trypsin inhibitor of bovine pancreas, which is an antifibrinolytic molecule that inhibits trypsin and related proteolytic enzymes. Under the trade name Trasylol, aprotinin was used as a medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.